Franklin Berger, Director at Five Prime Therapeutics, holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX), holds 306.16K shares in Kineta (Ticker: KANT), holds ― shares in Forte Biosciences (Ticker: FBRX).
Franklin Berger latest transaction was an Uninformative Sell of $190.00K.
What was Franklin Berger's most profitable transaction?
Franklin Berger’s most profitable transaction was an Informative Buy of FPRX stock on September 24, 2015. The return on the trade was 181.70%.
What is Franklin Berger's role in Five Prime Therapeutics?
Franklin Berger's role in Five Prime Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.